CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
48.32
+1.33 (2.83%)
Jul 21, 2026, 10:21 AM EDT - Market open
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.76 billion as of July 21, 2026. Its market cap has decreased by -15.40% in one year.
Market Cap
4.76B
Enterprise Value
2.97B
1-Year Change
-15.40%
Ranking
Category
Stock Price
$48.32
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.76B, an increase of 749.63%. That is a compound annual growth rate of 24.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 4.53B | -9.31% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 5.59B |
| Travere Therapeutics | 5.27B |
| Caris Life Sciences | 4.66B |
| Veradermics | 4.65B |
| ACADIA Pharmaceuticals | 4.38B |
| Relay Therapeutics | 4.34B |
| Celcuity | 4.31B |
| Legend Biotech | 4.31B |